Skip to main content
Top
Published in: AIDS Research and Therapy 1/2022

Open Access 01-12-2022 | Care | Research

Successful expanded clinic network collaboration and patient tracing for retention in HIV care

Authors: Shivani Bhatt, Mellissa Bryant, Helen Lau, Ban-Kiem Tee, Beng Eu, Jessica O’Bryan, Ian Woolley, Jeni Mitchell, Alan Street, Sheranne Dobinson, Nicholas Medland, Judy Lamb, Andrew Mahony, Adrian Tramontana, Lyn-Li Lim, Amanda Wade, Christine Roder, William Mitchell, Christopher Sherman, Fran Bramwell, Craig Aboltins, Siaw Hui Wong, Maxine Giourouki, Jennifer F Hoy, James H McMahon

Published in: AIDS Research and Therapy | Issue 1/2022

Login to get access

Abstract

Background

There are more than 7,800 people living with human immunodeficiency virus (HIV) in Victoria, Australia. Crucial in maximising the individual and population level benefits from antiretroviral therapy (ART) is understanding how to achieve patient retention in care and the factors that drive it. This study was an expansion of a 2015 assessment of HIV-care retention in Victoria, which sought out to determine whether the inclusion of a broader range of HIV-healthcare sites would yield more accurate estimates of retention in HIV-care. We aimed to improve our understanding of HIV-care retention in Victoria, Australia, identify people living with HIV (PLHIV) with unknown outcomes, and attempt to re-engage PLHIV in care.

Methods

A network of 15 HIV-care sites was established in Victoria, Australia across diverse care settings which ranged from low-caseload rural sites to high-caseload metropolitan GP clinics and hospitals. Individuals who had an HIV viral load (VL) performed in both calendar years of 2016 and 2017 were classified as retained in care. Individuals with a VL test in 2016 but not in 2017 were considered to potentially have unknown outcomes as they may have been receiving care elsewhere, have disengaged from care or died. For this group, an intervention of cross-referencing partially de-identified data between healthcare sites, and contact tracing individuals who still had unknown outcomes was performed.

Results

For 5223 individuals considered to be retained in care across 15 healthcare sites in the study period, 49 had unconfirmed transfers of care to an alternative provider and 79 had unknown outcomes. After the intervention, the number of unconfirmed care transfers was reduced to 17 and unknown outcomes reduced to 51. These changes were largely attributed to people being reclassified as confirmed transfers of care. Retention in care estimates that did not include the patient outcome of confirmed transfer of care ranged from 76.2 to 95.8% and did not alter with the intervention. However, retention in care estimates which considered confirmed transfers and those that re-entered care at a new site as retained in care significantly increased across five of the sites with estimates ranging from 80.9 to 98.3% pre-intervention to 83.3–100% post-intervention. Individuals whose outcomes remained unknown post-intervention were more often men who have sex with men (MSM) when compared to other categories (person who injects drugs (PWID), combined PWID/MSM, men who identify as heterosexual or unknown) (74.5% vs. 53.5%, [p = 0.06]) and receiving ART at their last HIV-care visit (84.3% vs. 67.8% [p = 0.09]).

Conclusion

This study confirmed high retention in HIV-care and low numbers of people disengaged from HIV-care in Victoria. This was demonstrated across a larger number of sites with varying models of care than a prior assessment in 2015. These data align with national and state targets aiming for 95% of PLHIV retained in HIV-care.
Literature
1.
go back to reference Kanters S, Vitoria M, Doherty M, Socias ME, Ford N, Forrest JI, et al. Comparative efficacy and safety of first-line antiretroviral therapy for the treatment of HIV infection: a systematic review and network meta-analysis. Lancet HIV. 2016;3(11):e510-e20.CrossRef Kanters S, Vitoria M, Doherty M, Socias ME, Ford N, Forrest JI, et al. Comparative efficacy and safety of first-line antiretroviral therapy for the treatment of HIV infection: a systematic review and network meta-analysis. Lancet HIV. 2016;3(11):e510-e20.CrossRef
2.
go back to reference Eisinger RW, Dieffenbach CW, Fauci AS. HIV Viral Load and Transmissibility of HIV Infection: Undetectable Equals Untransmittable. JAMA. 2019;321(5):451–2.CrossRef Eisinger RW, Dieffenbach CW, Fauci AS. HIV Viral Load and Transmissibility of HIV Infection: Undetectable Equals Untransmittable. JAMA. 2019;321(5):451–2.CrossRef
3.
go back to reference Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Antiretroviral Therapy for the Prevention of HIV-1 Transmission. N Engl J Med. 2016;375(9):830–9.CrossRef Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Antiretroviral Therapy for the Prevention of HIV-1 Transmission. N Engl J Med. 2016;375(9):830–9.CrossRef
6.
go back to reference McMahon JH, Moore R, Eu B, Tee BK, Chen M, El-Hayek C, et al. Clinic Network Collaboration and Patient Tracing to Maximize Retention in HIV Care. PLoS ONE. 2015;10(5):e0127726.CrossRef McMahon JH, Moore R, Eu B, Tee BK, Chen M, El-Hayek C, et al. Clinic Network Collaboration and Patient Tracing to Maximize Retention in HIV Care. PLoS ONE. 2015;10(5):e0127726.CrossRef
7.
go back to reference Van Beckhoven D, Lacor P, Moutschen M, Pierard D, Sasse A, Vaira D, et al. Factors associated with the continuum of care of HIV-infected patients in Belgium. J Int AIDS Soc. 2014;17(4 Suppl 3):19534.CrossRef Van Beckhoven D, Lacor P, Moutschen M, Pierard D, Sasse A, Vaira D, et al. Factors associated with the continuum of care of HIV-infected patients in Belgium. J Int AIDS Soc. 2014;17(4 Suppl 3):19534.CrossRef
8.
go back to reference Helleberg M, Haggblom A, Sonnerborg A, Obel N. HIV care in the Swedish-Danish HIV cohort 1995–2010, closing the gaps. PLoS ONE. 2013;8(8):e72257.CrossRef Helleberg M, Haggblom A, Sonnerborg A, Obel N. HIV care in the Swedish-Danish HIV cohort 1995–2010, closing the gaps. PLoS ONE. 2013;8(8):e72257.CrossRef
9.
go back to reference Nosyk B, Montaner JSG, Colley G, Lima VD, Chan K, Heath K, et al. The cascade of HIV care in British Columbia, Canada, 1996–2011: a population-based retrospective cohort study. Lancet Infect Dis. 2014;14(1):40–9.CrossRef Nosyk B, Montaner JSG, Colley G, Lima VD, Chan K, Heath K, et al. The cascade of HIV care in British Columbia, Canada, 1996–2011: a population-based retrospective cohort study. Lancet Infect Dis. 2014;14(1):40–9.CrossRef
12.
go back to reference Wilkinson AL, McMahon J, Cheah YS, Bradshaw CS, El-Hayek C, Stoove M. Paying the price in an era of HIV treatment as prevention: a retrospective study of the cost burden of HIV treatment for people living with HIV in Victoria, Australia. Sex Health. 2015;12(1):34–8.CrossRef Wilkinson AL, McMahon J, Cheah YS, Bradshaw CS, El-Hayek C, Stoove M. Paying the price in an era of HIV treatment as prevention: a retrospective study of the cost burden of HIV treatment for people living with HIV in Victoria, Australia. Sex Health. 2015;12(1):34–8.CrossRef
13.
go back to reference Rathbun RC, Lockhart SM, Stephens JR. Current HIV treatment guidelines–an overview. Curr Pharm Des. 2006;12(9):1045–63.CrossRef Rathbun RC, Lockhart SM, Stephens JR. Current HIV treatment guidelines–an overview. Curr Pharm Des. 2006;12(9):1045–63.CrossRef
15.
go back to reference Bradley H, Hall HI, Wolitski RJ, Van Handel MM, Stone AE, LaFlam M, et al. Vital Signs: HIV diagnosis, care, and treatment among persons living with HIV–United States, 2011. MMWR Morb Mortal Wkly Rep. 2014;63(47):1113–7. Bradley H, Hall HI, Wolitski RJ, Van Handel MM, Stone AE, LaFlam M, et al. Vital Signs: HIV diagnosis, care, and treatment among persons living with HIV–United States, 2011. MMWR Morb Mortal Wkly Rep. 2014;63(47):1113–7.
16.
go back to reference Mey A, Plummer D, Dukie S, Rogers GD, O’Sullivan M, Domberelli A. Motivations and Barriers to Treatment Uptake and Adherence Among People Living with HIV in Australia: A Mixed-Methods Systematic Review. AIDS Behav. 2017;21(2):352–85.CrossRef Mey A, Plummer D, Dukie S, Rogers GD, O’Sullivan M, Domberelli A. Motivations and Barriers to Treatment Uptake and Adherence Among People Living with HIV in Australia: A Mixed-Methods Systematic Review. AIDS Behav. 2017;21(2):352–85.CrossRef
17.
go back to reference Bulsara SM, Wainberg ML, Audet CM, Newton-John TRO. Retention in HIV Care in Australia: The Perspectives of Clinicians and Clients, and the Impact of Medical and Psychosocial Comorbidity. AIDS Patient Care STDS. 2019;33(10):415–24.CrossRef Bulsara SM, Wainberg ML, Audet CM, Newton-John TRO. Retention in HIV Care in Australia: The Perspectives of Clinicians and Clients, and the Impact of Medical and Psychosocial Comorbidity. AIDS Patient Care STDS. 2019;33(10):415–24.CrossRef
Metadata
Title
Successful expanded clinic network collaboration and patient tracing for retention in HIV care
Authors
Shivani Bhatt
Mellissa Bryant
Helen Lau
Ban-Kiem Tee
Beng Eu
Jessica O’Bryan
Ian Woolley
Jeni Mitchell
Alan Street
Sheranne Dobinson
Nicholas Medland
Judy Lamb
Andrew Mahony
Adrian Tramontana
Lyn-Li Lim
Amanda Wade
Christine Roder
William Mitchell
Christopher Sherman
Fran Bramwell
Craig Aboltins
Siaw Hui Wong
Maxine Giourouki
Jennifer F Hoy
James H McMahon
Publication date
01-12-2022
Publisher
BioMed Central
Published in
AIDS Research and Therapy / Issue 1/2022
Electronic ISSN: 1742-6405
DOI
https://doi.org/10.1186/s12981-022-00476-x

Other articles of this Issue 1/2022

AIDS Research and Therapy 1/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine